chr8-130780564-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001115.3(ADCY8):c.3582G>A(p.Ala1194=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00139 in 1,614,130 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0074 ( 14 hom., cov: 32)
Exomes 𝑓: 0.00077 ( 13 hom. )
Consequence
ADCY8
NM_001115.3 synonymous
NM_001115.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.64
Genes affected
ADCY8 (HGNC:239): (adenylate cyclase 8) Adenylate cyclase is a membrane bound enzyme that catalyses the formation of cyclic AMP from ATP. The enzymatic activity is under the control of several hormones, and different polypeptides participate in the transduction of the signal from the receptor to the catalytic moiety. Stimulatory or inhibitory receptors (Rs and Ri) interact with G proteins (Gs and Gi) that exhibit GTPase activity and they modulate the activity of the catalytic subunit of the adenylyl cyclase [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 8-130780564-C-T is Benign according to our data. Variant chr8-130780564-C-T is described in ClinVar as [Benign]. Clinvar id is 713272.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.64 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00737 (1122/152274) while in subpopulation AFR AF= 0.0255 (1061/41556). AF 95% confidence interval is 0.0243. There are 14 homozygotes in gnomad4. There are 527 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1122 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADCY8 | NM_001115.3 | c.3582G>A | p.Ala1194= | synonymous_variant | 18/18 | ENST00000286355.10 | |
ADCY8 | XM_005250769.4 | c.3492G>A | p.Ala1164= | synonymous_variant | 17/17 | ||
ADCY8 | XM_006716501.4 | c.3384G>A | p.Ala1128= | synonymous_variant | 17/17 | ||
ADCY8 | XM_017013006.2 | c.3294G>A | p.Ala1098= | synonymous_variant | 16/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADCY8 | ENST00000286355.10 | c.3582G>A | p.Ala1194= | synonymous_variant | 18/18 | 1 | NM_001115.3 | P1 | |
ADCY8 | ENST00000377928.7 | c.3189G>A | p.Ala1063= | synonymous_variant | 15/15 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00737 AC: 1121AN: 152156Hom.: 14 Cov.: 32
GnomAD3 genomes
AF:
AC:
1121
AN:
152156
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00192 AC: 482AN: 251150Hom.: 7 AF XY: 0.00148 AC XY: 201AN XY: 135722
GnomAD3 exomes
AF:
AC:
482
AN:
251150
Hom.:
AF XY:
AC XY:
201
AN XY:
135722
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000768 AC: 1122AN: 1461856Hom.: 13 Cov.: 35 AF XY: 0.000679 AC XY: 494AN XY: 727228
GnomAD4 exome
AF:
AC:
1122
AN:
1461856
Hom.:
Cov.:
35
AF XY:
AC XY:
494
AN XY:
727228
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00737 AC: 1122AN: 152274Hom.: 14 Cov.: 32 AF XY: 0.00708 AC XY: 527AN XY: 74456
GnomAD4 genome
AF:
AC:
1122
AN:
152274
Hom.:
Cov.:
32
AF XY:
AC XY:
527
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 23, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at